Integrated Molecular Characterization of the Lethal Pediatric Cancer Pancreatoblastoma

Integrated Molecular Characterization of the Lethal Pediatric Cancer Pancreatoblastoma
复制标题

DOI:
10.1158/0008-5472.can-17-2581
复制
发表时间:
2018-02-15
期刊:
影响因子:
11.2
通讯作者:
Takita, Junko
Takita, Junko
中科院分区:
医学1区
文献类型:
--
作者:
Isobe, Tomoya;Seki, Masafumi;Takita, Junko

文献摘要

被引文献

相似文献

胰腺母细胞瘤是一种罕见的儿童胰腺恶性肿瘤,其分子发病机制尚不清楚。在这项研究中,我们报告了一个完整的外显子组和RNA测序以及全基因组拷贝数和甲基化分析的10例胰腺母细胞瘤的多组学研究的结果。胰腺母细胞瘤基因组的特征在于Wnt信号通路的高频率异常激活,通过CTNNB 1的体细胞突变(90%)和APC的拷贝中性杂合性丢失(CN-LOH)(10%)。此外,普遍检测到CN-LOH(80%)、父本等位基因获得(10%)和甲基化获得(10%)导致的IGF 2印迹失调。在转录组水平,胰腺母细胞瘤表现出早期胰腺祖细胞样细胞的表达特征,沿着R-spondin/LGR 5/RNF 43模块的上调。我们的研究结果提供了一个全面的描述胰腺母细胞瘤的分子基础,并突出合理的治疗靶点,其treatment.Significance:一种罕见的无法治疗的儿科肿瘤的分子遗传学分析揭示了Wnt/IGF 2畸变和早期胰腺祖细胞样细胞的功能,这表明细胞起源和合理的治疗靶向策略。(C)2017年AACR。
Pancreatoblastoma is a rare pediatric pancreatic malignancy for which the molecular pathogenesis is not understood. In this study, we report the findings of an integrated multiomics study of whole-exome and RNA sequencing as well as genome-wide copy number and methylation analyses of ten pancreatoblastoma cases. The pancreatoblastoma genome was characterized by a high frequency of aberrant activation of the Wnt signaling pathway, either via somatic mutations of CTNNB1 (90%) and copy-neutral loss of heterozygosity (CN-LOH) of APC (10%). In addition, imprinting dysregulation of IGF2 as a consequence of CN-LOH (80%), gain of paternal allele (10%), and gain of methylation (10%) was universally detected. At the transcriptome level, pancreatoblastoma exhibited an expression profile characteristic of early pancreas progenitor-like cells along with upregulation of the R-spondin/LGR5/RNF43 module. Our results offer a comprehensive description of the molecular basis for pancreatoblastoma and highlight rational therapeutic targets for its treatment.Significance: Molecular genetic analysis of a rare untreatable pediatric tumor reveals Wnt/IGF2 aberrations and features of early pancreas progenitor-like cells, suggesting cellular origins and rational strategies for therapeutic targeting. (C) 2017 AACR.